(Q48459353)

11 February 2018

title

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. (English)

1 reference

11 February 2018

0 references

9

1 reference

11 February 2018

Demian Obregon

7

object named as

Demian Obregon

1 reference

11 February 2018

Richard Flavell

8

object named as

Richard A Flavell

1 reference

11 February 2018

author name string

Jun Tan

1

1 reference

11 February 2018

Terrence Town

2

1 reference

11 February 2018

Fiona Crawford

3

1 reference

11 February 2018

Takashi Mori

4

1 reference

11 February 2018

Anthony DelleDonne

5

1 reference

11 February 2018

Robert Crescentini

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

11 February 2018

published in

Nature Neuroscience

1 reference

11 February 2018

volume

5

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

1288-1293

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/nn968

exact match

0 references

cites work

Alzheimer's disease: genes, proteins, and therapy

1 reference

7 January 2021

The importance of inflammatory mechanisms in Alzheimer disease.

1 reference

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

7 January 2021

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

1 reference

7 January 2021

Microglia and the immune pathology of Alzheimer disease

1 reference

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

7 January 2021

Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta

1 reference

7 January 2021

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

1 reference

7 January 2021

Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury

1 reference

7 January 2021

Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

7 January 2021

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

1 reference

7 January 2021

A new definition of Alzheimer's disease: a hippocampal dementia

1 reference

7 January 2021

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

1 reference

7 January 2021

CD40 is expressed and functional on neuronal cells

1 reference

7 January 2021

Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus

1 reference

7 January 2021

Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta

1 reference

7 January 2021

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

7 January 2021

Role of CD40-CVD40L in mouse severe malaria

1 reference

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

1 reference

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

7 January 2021

Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels

1 reference

7 January 2021

Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice

1 reference

7 January 2021

Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse

1 reference

7 January 2021

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

7 January 2021

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

7 January 2021

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

1 reference

7 January 2021

Mice deficient for the CD40 ligand

1 reference

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN968

1 reference

11 February 2018

PubMed ID

12402041

1 reference

11 February 2018